Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.00%||68.93||1.0%||$502.66m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.93%||630.59||2.7%||$480.14m|
|VRTX||Vertex Pharmaceuticals, Inc.||9.66%||205.00||1.9%||$469.49m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-10.85%||4.11||0.7%||$287.30m|
|EXAS||EXACT Sciences Corp.||-5.96%||80.28||18.0%||$157.41m|
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.